Ascent Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Ascent Group's AMGN Position: Q2 2026 in Review
Ascent Group reduced its Amgen (AMGN) stake by 0.98% in Q2 2026, selling an estimated $26.7K and leaving 7,847 shares worth $2.84M. The position accounts for 0.09% of the portfolio, ranked #209.
Ascent Group first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.95M in Q2 2022. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ascent Group held 7,847 shares of Amgen worth $2.84M as of Q2 2026.
- Ascent Group sold 78 Amgen shares in Q2 2026, an estimated $26.7K.
- Amgen made up 0.09% of Ascent Group's portfolio in Q2 2026, its #209 holding.
- Ascent Group first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Ascent Group's Amgen position peaked at $6.95M in Q2 2022.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.